Development and Validation of Bio Analytical Method for Estimation of Bortezomib in k3 EDTA Human Plasma Using HPLC-ESI-MS/MS and Its Application to a Bioequivalence & CME Studies

Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 14, Issue 4

Abstract

Purpose: To develop a highly selective, reproducible & precise rugged bio analytical method for estimation of Bortezomib (BTZ), “A Protease Inhibitor” in human plasma by validating the developed method in accordance to US-FDA guidelines. Methodology Envisaged: BTZ D3 was used as an internal standard (ISTD) for the determination of BTZ in human plasma using a rapid & specific liquid chromatographic – Electron Spray Ionization –Mass spectrometric method. The analytical method was moduled with liquid-liquid phase extraction by using annular centrifugal contactor & the samples were analyzed by HPLC, on a column - ACE 5CN (150 x 4.6 mm 5 µm), using mobile phase consisting of ammonium formate buffer: ACN (25:75 v/v), delivered at 1.0 ml/min & 90% flow spitting. Applied Bio system MDS Sciex API 3000 Triple Quadruple MS equipped with Turbo Ion Spray (TIS) as LC/MS interface was used in for MS detection. TIS with multiple reaction monitoring (MRM) were acquired by ESI mass spectra, using the transitions m/z 362.95→310.21 & m/z 172.64→146.06 to quantify BTZ & BTZ D3 respectively. Results: % variability was ≤ 5.52 & ≤ 6.15 [that was ≤ 15], indicating the specificity of the method, showing no matrix interferences across the elution system. Acceptance is ranging between -8.30 to 2.83 & -4.32 to 1.00% (< 5% CV) & accuracy in the range of 92.73 – 102.20 (< 10% difference) was observed over a linear range of 2.00 – 1000 ng/mL. The mean (n=3) correlation coefficient was 0.9991 & overall mean recovery was 85.62%. Retention time for drug & ISTD is found out to be 0.08 & 0.07; % CV of area ratio is 1.91% & area ratio ≤ 2.51%, which indicated system suitability. Interpretation and Conclusion: The intended analyte is stable below 10ºC in all the performed stability experimentation & within the acceptance limits. It can be used for investigating drug concentration in routine quality control analysis in API & its pharmaceutical dosage forms.

Authors and Affiliations

Ravi Pratap Pulla, K. Vanitha Prakash, U. B. Abhini, B. Naga Maheswari, V. Divya, M. V. Shushmitha

Keywords

Related Articles

Efficacy of Vitamin B6 on Pregnancy Outcomes: A Randomized Clinical Trial

Background: Postpartum depression is a common and disabling disorder. A low level of vitamin B6 might theoretically causes symptoms of depression. The aim of this study was to investigate the effect of vitamin B6 on Preg...

Senecio pterophorus DC. (Asteraceae) Essential Oils: Antibacterial, Antioxidant, Cytotoxic and Larvicidal Activities

The antibacterial, antioxidant, cytotoxic and larvicidal activities of essential oils obtained by hydrodistillation from the leaves of Senecio pterophorus DC were investigated in the present study. The oils were tested f...

Molecular Characterization Using gtf Gene Detection and Medium Optimization of Beta-D-Glucan Production from Pediococcus parvulus F1030 Isolated from Local Egyptian Boza

Background: Lactic acid bacteria (LAB) have great benefits which can improve the nutritional value of food, reduces some infections, immune modulator effect, curbs some types of cancer and restricts glucose level of seru...

Angiogenesis and Antioxidant Activity of in vitro and in vivo Tuber of Ceropegia pusilla Wight and Arn

Background: Angiogenesis refers to the formation of new blood vessels. This biological process lays an important role in embryonic development. Ceropegia pusilla (Asclepiadaceae) used in folk medicine system to treat var...

Development and Evaluation of Ophthalmic Drop and In-situ Gel from Roots of Boerhaavia diffusa

The present investigation deals to evaluate efficacy of ophthalmic drop and in-situ gel formulations of aqueous distillate of Boerhaavia diffusa roots using polymers sodium alginate (SA), HPMC (hydroxyl propyl methyl cel...

Download PDF file
  • EP ID EP342251
  • DOI 10.9734/BJPR/2016/30565
  • Views 106
  • Downloads 0

How To Cite

Ravi Pratap Pulla, K. Vanitha Prakash, U. B. Abhini, B. Naga Maheswari, V. Divya, M. V. Shushmitha (2016). Development and Validation of Bio Analytical Method for Estimation of Bortezomib in k3 EDTA Human Plasma Using HPLC-ESI-MS/MS and Its Application to a Bioequivalence & CME Studies. Journal of Pharmaceutical Research International, 14(4), 1-17. https://europub.co.uk./articles/-A-342251